KalVista Pharmaceuticals Ltd - developing novel therapies for heredita

- kalvista.biz

KalVista Pharmaceuticals - developing novel therapies for hereditary angioedema and diabetic macular edema based on small molecule plasma kallikrein inhibitors

Not Applicable $ 8.95